We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:5716U
GW Pharmaceuticals PLC
23 January 2004
GW Pharmaceuticals plc ("the Company")
Option exercise and application to AIM
Pursuant to the exercise by a Consultant of a option over 8,000 new ordinary
shares of 0.1p each in the Company ("New Ordinary Shares") at a price of 20.52p
per share, the Company has today issued and allotted the New Ordinary Shares and
applied for them to be admitted to the Alternative Investment Market of the
London Stock Exchange. Such admission is expected to become effective on
Thursday 29 January 2004.
23 January 2004
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISBBGDBDSDGGSX
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
